MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines.

Abstract:

:PFN2 is an invasion promoter in several cancers including lung cancer. However, the probable effects and underlying mechanisms of PFN2 in tumor cell epithelial-mesenchymal-transition (EMT) of non-small cell lung cancer (NSCLC) remain poorly understood. The protein and mRNA levels of PFN2 in human bronchial epithelial cell line 16HBE and three NSCLC cell lines A549, NCI-H520 and 95D were assessed. The gain-of-function (overexpression) and loss‑of-function (siRNA) experiments of PFN2 were performed in 95D cells. A dual-luciferase reporter assay, western blotting and real-time PCR were used to investigate the relationship between PFN2 and miR‑30a‑5p. PFN2 was upregulated in three NSCLC cell lines, and the highest in 95D cell line. Furthermore, the upregulation of PFN2 promoted, whereas the downregulation of PFN2 suppressed invasion and EMT in 95D. Dual-luciferase reporter assay showed that miR‑30a‑5p directly interacts with the 3'-untranslated region (3'-UTR) of PFN2 mRNA. Interestingly, miR‑30a‑5p negatively regulates the expression of PFN2 and suppresses EMT and invasion in 95D. In summary, the present study demonstrated that miR‑30a‑5p inhibits EMT and invasion in high invasive NSCLC cell lines via targeting PFN2. Suggesting the association of miR‑30a‑5p and PFN2 may play an essential role in the development of NSCLC by modulating EMT and cell invasion.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Yan J,Ma C,Gao Y

doi

10.3892/or.2017.5566

subject

Has Abstract

pub_date

2017-05-01 00:00:00

pages

3146-3154

issue

5

eissn

1021-335X

issn

1791-2431

journal_volume

37

pub_type

杂志文章
  • Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells.

    abstract::At present, acute promyelocytic leukemia (APL) is the most curable form of acute myeloid leukemia and can be treated using all-trans retinoic acid and arsenic trioxide. However, the current treatment of APL is associated with some issues such as drug toxicity, resistance and relapse. Therefore, other strategies are ne...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6513

    authors: Zhao Y,Zhong L,Liu L,Yao SF,Chen M,Li LW,Shan ZL,Xiao CL,Gan LG,Xu T,Liu BZ

    更新日期:2018-08-01 00:00:00

  • Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.

    abstract::Vascular endothelial growth factor C (VEGF-C), a member of VEGF gene family, is considered to induce both lymph node metastasis and lymphatic involvement in various cancers related to lymphangiogenesis. We examined the relationship between VEGF-C expression and clinicopathological features in 112 Japanese patients wit...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.10.6.1747

    authors: Kimura Y,Watanabe M,Ohga T,Saeki H,Kakeji Y,Baba H,Maehara Y

    更新日期:2003-11-01 00:00:00

  • Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a member of the nuclear hormone receptor superfamily, is involved in suppressing the growth of several tumors. We showed that PPAR-gamma is expressed in Barrett's adenocarcinoma cell lines and inhibited the growth of these lines through the induction of G1...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Takashima T,Fujiwara Y,Hamaguchi M,Sasaki E,Tominaga K,Watanabe T,Oshitani N,Higuchi K,Arakawa T

    更新日期:2005-04-01 00:00:00

  • A reduced COX-2 expression and a reduced number of pericryptal myofibroblasts are associated with depressed adenoma of the colon.

    abstract::The histogenesis of depressed adenoma of the colon has not been sufficiently investigated. Pericryptal myofibroblasts are stromal cells expressing smooth muscle actin, and are involved in the differentiation and multiplication of epithelial cells in the colonic epithelium. COX-2 has been reported to be involved in the...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Harada K,Higaki S,Amano A,Hashimoto K,Hashimoto S,Gondo T,Sakaida I

    更新日期:2007-06-01 00:00:00

  • Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1.

    abstract::Statins are the most effective drugs used in the reduction of intracellular synthesis of cholesterol. Numerous studies have confirmed that statins reduce the risk of multiple types of cancers. Statin use in cancer patients is associated with reduced cancer-related mortality. Epithelial-to-mesenchymal transition (EMT),...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4897

    authors: Fan Z,Jiang H,Wang Z,Qu J

    更新日期:2016-08-01 00:00:00

  • Overexpression of WNT5B promotes COLO 205 cell migration and invasion through the JNK signaling pathway.

    abstract::WNT5B is a member of the WNT family that has been reported to be overexpressed in a variety of cancer cell lines and tissues, including colorectal cancer (CRC). However, the potential roles of WNT5B in tumorigenesis have not been reported. In the present study, the WNT5B gene was transfected into CRC cells and generat...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4772

    authors: Zhang Y,Lin L,Jin Y,Lin Y,Cao Y,Zheng C

    更新日期:2016-07-01 00:00:00

  • Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib.

    abstract::New therapeutic approaches are mandatory for anaplastic thyroid cancer. We investigated the ability of a new combined treatment using valproic acid (VPA), the only clinically available histone deacetylase inhibitor, and the tyrosine-kinase inhibitor imatinib mesylate to control the cell growth of anaplastic thyroid ca...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Catalano MG,Pugliese M,Poli R,Bosco O,Bertieri R,Fortunati N,Boccuzzi G

    更新日期:2009-02-01 00:00:00

  • Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine.

    abstract::Genetically modified tumour cells producing cytokines such as interleukin 12 (IL-12) are potent activators of the antitumour immune responses and represent a promising therapeutic modality when combined with chemotherapy. The objective of this study was to examine whether IL-12-producing cellular vaccines can augment ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1221

    authors: Mikyšková R,Indrová M,Símová J,Bieblová J,Bubeník J,Reiniš M

    更新日期:2011-06-01 00:00:00

  • Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection.

    abstract::Glucose intolerance frequently is found in hepatocellular carcinoma (HCC) patients with hepatitis C virus (HCV) infection; however, the significance of glucose intolerance remains unclear. In addition, SH2 domain-containing inositol phosphatase (SHIP) 2 is a negative regulator of intracellular insulin signaling; howev...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Sumie S,Kawaguchi T,Komuta M,Kuromatsu R,Itano S,Okuda K,Taniguchi E,Ando E,Takata A,Fukushima N,Koga H,Torimura T,Kojiro M,Sata M

    更新日期:2007-09-01 00:00:00

  • The role of MTA1 gene expression in human hepatocellular carcinoma.

    abstract::The MTA1 gene has been identified as metastasis-associated gene and has been seen to correlate with the degree of invasion and lymphatic metastasis in gastric, colorectal, and esophageal carcinomas. We investigated the possible role of MTA1 gene expression in hepatocellular carcinoma (HCC). The mRNA expression level o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Hamatsu T,Rikimaru T,Yamashita Y,Aishima S,Tanaka S,Shirabe K,Shimada M,Toh Y,Sugimachi K

    更新日期:2003-05-01 00:00:00

  • Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.

    abstract::Breast cancer is the most common cancer in women worldwide. Progression and aggressiveness of breast cancer is usually associated with its migration and invasion abilities. Recently, natural products with potential anticancer activity have become attractive candidates for alternative treatment of cancer. A fungal meta...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6189

    authors: Kasorn A,Loison F,Kangsamaksin T,Jongrungruangchok S,Ponglikitmongkol M

    更新日期:2018-03-01 00:00:00

  • Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.

    abstract::S-1 is an oral antitumor agent that contains tegafur, which is converted to fluorouracil (5-FU) in the human body. Cytochrome P450 2A6 (CYP2A6) is the principal enzyme responsible for bioconversion of tegafur to 5-FU. A number of CYP2A6 polymorphisms have been associated with variat...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1678

    authors: Fang WJ,Mou HB,Jin DZ,Zheng YL,Zhao P,Mao CY,Peng L,Huang MZ,Xu N

    更新日期:2012-05-01 00:00:00

  • [Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells.

    abstract::Subsequently to the publication of the above paper, the authors have drawn to our attention that, owing to errors made in the compilation of the images in Fig. 6, the images shown in Fig. 6A‑C in the article were selected incorrectly (essentially, the images shown in Fig. 6A and B were alterative presentations of the ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7903

    authors: Chen YH,Zhou BY,Wu XJ,Xu JF,Zhang JA,Chen YH,Liang SS

    更新日期:2020-12-16 00:00:00

  • Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells.

    abstract::In order to clarify the molecular mechanism involved in renal carcinogenesis, and to identify molecular targets for development of novel treatments of renal cell carcinoma (RCC), we previously analyzed genome-wide gene expression profiles of clear-cell types of RCC by cDNA microarray. Among the transcativated genes, w...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Dobashi S,Katagiri T,Hirota E,Ashida S,Daigo Y,Shuin T,Fujioka T,Miki T,Nakamura Y

    更新日期:2009-02-01 00:00:00

  • Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.

    abstract::Inhibins are dimeric glycoproteins, composed of an α-subunit and one of two possible β-subunits (βA or βB), with substantial roles in human reproduction and in endocrine-responsive tumours. Recently a novel β subunit named βC was described, although it is still unclear if normal or cancerous cervical epithelial cells ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Blankenstein T,Jückstock J,Shabani N,Kunze S,Brüning A,Bergauer F,Mylonas I

    更新日期:2011-01-01 00:00:00

  • Vesicular stomatitis virus is a potent agent for the treatment of malignant ascites.

    abstract::Cancer cells in ascites are usually exposed to a hypoxia tumor microenvironment and utilize enhanced glycolysis which produces energy and metabolizes nutrients to support proliferation. Vesicular stomatitis virus (VSV) is an oncolytic virus that relies on the host cellular metabolism for replication. We tested the eff...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4522

    authors: Zhou Y,Wen F,Zhang P,Tang R,Li Q

    更新日期:2016-03-01 00:00:00

  • Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.

    abstract::Apart from genetic mutations, epigenetic alteration is a common phenomenon that contributes to neoplastic transformation in colorectal cancer. Transcriptional silencing of tumor-suppressor genes without changes in the DNA sequence is explained by the existence of promoter hypermethylation. To test this hypothesis, we ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3993

    authors: Kok-Sin T,Mokhtar NM,Ali Hassan NZ,Sagap I,Mohamed Rose I,Harun R,Jamal R

    更新日期:2015-07-01 00:00:00

  • Diagnostic and therapeutic role of microRNAs in oral cancer (Review).

    abstract::Oral cancer is one of the leading types of cancer and remains the most common cause of cancer‑related mortality in Asia. The pathogenesis of oral cancer is complicated and, due to lack of accurate diagnostic methods and efficient treatment strategies, oral cancer is responsible for a large number of deaths. Therefore,...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7854

    authors: Wang J,Lv N,Lu X,Yuan R,Chen Z,Yu J

    更新日期:2021-01-01 00:00:00

  • Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells.

    abstract::Gentian violet (GV) is a cationic triphenylmethane dye, with potent antifungal and antibacterial activity. We recently reported that in vitro GV suppresses the differentiation of bone resorbing osteoclasts while stimulating the differentiation and activity of bone forming osteoblasts. Breast cancer is highly metastati...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4190

    authors: Yamaguchi M,Vikulina T,Weitzmann MN

    更新日期:2015-10-01 00:00:00

  • Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review).

    abstract::Treatment of patients affected by advanced or inoperable GIST was revolutionized by the use of the tyrosine kinase inhibitors. Despite the fact that most patients have a good durable response of disease, they develop a resistance to treatments after a median time of 24 months. The acquired resistance is an emerging as...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or_00000361

    authors: Maleddu A,Pantaleo MA,Nannini M,Di Battista M,Saponara M,Lolli C,Biasco G

    更新日期:2009-06-01 00:00:00

  • Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.

    abstract::Primarily through in vitro studies, the Rho-family of small GTPases and their effector proteins have been implicated in mediating oncogenic properties of cancer cells. We sought to determine if pharmacological inhibition of the RhoA effector proteins known as Rho-kinases (ROCK) with the small molecule inhibitor Y-2763...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Routhier A,Astuccio M,Lahey D,Monfredo N,Johnson A,Callahan W,Partington A,Fellows K,Ouellette L,Zhidro S,Goodrow C,Smith A,Sullivan K,Simone P,Le L,Vezuli B,Zohni M,West E,Gleason D,Bryan B

    更新日期:2010-03-01 00:00:00

  • Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer.

    abstract::Thioridazine, an antipsychotic drug, has been reported to induce apoptosis in various types of cancer cells, with specificity on targeting cancer stem cells (CSCs). However, whether it elicits anticancer effects in gastric cancer has never been reported. In the present study, we examined the ability of thioridazine to...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3068

    authors: Mu J,Xu H,Yang Y,Huang W,Xiao J,Li M,Tan Z,Ding Q,Zhang L,Lu J,Wu X,Liu Y

    更新日期:2014-05-01 00:00:00

  • ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.

    abstract::Apoptosis repressor with caspase recruitment domain (ARC), an inhibitor of apoptosis, is primarily expressed in terminally differentiated tissues. Recent studies have revealed that ARC is highly expressed in a variety of human cancer cell lines and epithelial-derived cancers, which suggests that ARC plays an important...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2622

    authors: Wu P,Tang Y,He J,Qi L,Jiang W,Zhao S

    更新日期:2013-10-01 00:00:00

  • A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.

    abstract::The majority of patients with hormone receptor-positive metastatic breast cancer die from disease progression despite different types of anti-hormonal treatments. Preclinical studies have indicated that resistance to anti-hormonal therapies may be the result of an activated NF-κB si...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1562

    authors: Trinh XB,Sas L,Van Laere SJ,Prové A,Deleu I,Rasschaert M,Van de Velde H,Vinken P,Vermeulen PB,Van Dam PA,Wojtasik A,De Mesmaeker P,Tjalma WA,Dirix LY

    更新日期:2012-03-01 00:00:00

  • The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells.

    abstract::Codonolactone (CLT), a natural product, is the major bioactive component of Atractylodes lancea, and also found in a range of other medical herbs, such as Codonopsis pilosula, Chloranthus henryi Hemsl and Atractylodes macrocephala Koidz. This sesquiterpene lactone has been demonstrated to exhibit a range of activities...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4394

    authors: Fu J,Ke X,Tan S,Liu T,Wang S,Ma J,Lu H

    更新日期:2016-01-01 00:00:00

  • Ibuprofen enhances TRAIL-induced apoptosis through DR5 upregulation.

    abstract::Numerous human chemoprevention studies have demonstrated that non-steroidal anti-inflammatory drugs (NSAIDs) possess chemopreventive effects against a variety of malignant tumors. However, there have been many clinical studies on aspirin, but not ibuprofen, even though ibuprofen is one of the most clinically and safel...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2713

    authors: Todo M,Horinaka M,Tomosugi M,Tanaka R,Ikawa H,Sowa Y,Ishikawa H,Fujiwara H,Otsuji E,Sakai T

    更新日期:2013-11-01 00:00:00

  • TIPE2 inhibits GC via regulation of cell proliferation, apoptosis and inflammation.

    abstract::Gastric cancer (GC), a type of gastric mucosal epithelium disease caused by common malignant tumors, has become a major threat to human health and survival. Tumor necrosis factor‑α‑induced protein‑8 like‑2 (TIPE2) is a negative immune regulatory factor that is selectively expressed in immune organs, immune cells and v...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6576

    authors: Lin Z,Liu W,Xiao C,Fan Y,Zhuang G,Qi Z

    更新日期:2018-09-01 00:00:00

  • Oncogenic chromosomal translocations and human cancer (review).

    abstract::Chromosomal translocations are very common in human cancer. The molecular mechanisms of chromosomal translocations are complex and are not fully understood. Recent studies showed organization of genomes is higher-order in the nucleus and every chromosome or chromatin has its preferential position and territory. These ...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2013.2677

    authors: Zheng J

    更新日期:2013-11-01 00:00:00

  • Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells.

    abstract::Breast cancer is one of the most common malignancies diagnosed in women and it is increasing in incidence. Siegesbeckia glabrescens (SG) has been used in traditional oriental medicine to treat cardiovascular diseases such as hypertension and angina pectoris. This study examined whether or not SG could induce apoptosis...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Jun SY,Choi YH,Shin HM

    更新日期:2006-06-01 00:00:00

  • Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA.

    abstract::Although many studies have been conducted on the role of alternative medicine in the treatment of cancer, only a few reports have been published regarding the total regression of malignant tumors. At the PBH Research Foundation (PBHRF), two of the authors have used homoeopathic therapy to treat many patients with vari...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Banerji P,Campbell DR,Banerji P

    更新日期:2008-07-01 00:00:00